<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>COVID-19: Acute limb ischemia</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">COVID-19: Acute limb ischemia</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">COVID-19: Acute limb ischemia</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Max Wohlauer, MD, RPVI</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Yana Etkin, MD, FACS</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joseph L Mills, Sr, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John F Eidt, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mark A Creager, MD, FAHA, FACC, MSVM</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kathryn A Collins, MD, PhD, FACS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 31, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H943113508"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Coagulation defects have been described with respiratory viruses including severe acute respiratory syndrome coronavirus 1 (SARS CoV-1), Middle East respiratory syndrome coronavirus [MERS-CoV], and severe acute respiratory virus syndrome coronavirus 2 [SARS-CoV-2] [<a href="#rid1">1-7</a>]. Findings suggest that endothelial dysfunction, inflammation, cytokine release, hypercoagulability, and hypoxia contribute to thrombosis [<a href="#rid2">2,8-10</a>]. Thrombotic complications in patients with coronavirus disease 2019 (COVID-19) present in a variety of ways, most commonly with venous thromboembolism, but also with ischemic complications related to thrombosis of extremity, cerebral, coronary, and visceral arteries. Early recognition of acute limb ischemia (ALI), which is a sudden decrease in the perfusion to an extremity, and intervention, when possible, can help reduce mortality in these very ill patients and maximize the chance for limb salvage. </p><p>Risk factors for COVID-19 associated ALI and management are reviewed. Other clinical features and the diagnosis of COVID-19 and coagulation disorders associated with COVID-19 are reviewed separately. (See  <a class="medical medical_review" href="/d/html/128323.html" rel="external">"COVID-19: Clinical features"</a> and  <a class="medical medical_review" href="/d/html/127926.html" rel="external">"COVID-19: Hypercoagulability"</a>.)</p><p class="headingAnchor" id="H868036051"><span class="h1">INCIDENCE AND DISTRIBUTION</span><span class="headingEndMark"> — </span>The data available on the incidence and characteristics of arterial thromboembolic complications in patients with COVID-19 come from a handful of case series and individual case reports. Early in the experience of COVID-19, the reported incidence of ALI in patients with COVID-19 who required hospitalization ranged from 3 to 15 percent [<a href="#rid11">11-13</a>]. Later literature suggested that the incidence of ALI in these patients was lower than reported in the beginning of the pandemic. In a meta-analysis of 15 studies (37,217 patients), the incidence of ALI was 0.3 percent in all hospitalized COVID-19 patients [<a href="#rid14">14</a>]. It is observed to be higher in critically ill patients. Another systematic review of five cohort studies reported a 2.5 prevalence of ALI in critically ill patients with COVID-19 [<a href="#rid15">15</a>]. </p><p>By comparison, the rate of ALI in the general population is approximately 10 to 15 per 100,000 per year (about 30,000 to 50,000 cases) and includes embolic, thrombotic, and traumatic etiologies [<a href="#rid16">16</a>]. Risk factors for ALI (in general) include atrial fibrillation and other cardiac sources of thromboembolism, trauma, dissection, peripheral artery disease (PAD), and hypercoagulability related to inherited or acquired conditions and malignancy. Among patients with PAD, ALI is reported to occur in approximately 1.7 to 7 percent (data collected before the COVID-19 pandemic) [<a href="#rid17">17,18</a>]. (See  <a class="medical medical_review" href="/d/html/8213.html" rel="external">"Clinical features and diagnosis of acute lower extremity ischemia", section on 'Etiologies'</a> and  <a class="medical medical_review" href="/d/html/118660.html" rel="external">"Overview of upper extremity ischemia", section on 'Incidence and etiologies'</a>.)</p><p class="headingAnchor" id="H93064757"><span class="h2">Etiology and anatomic distribution</span><span class="headingEndMark"> — </span>In patients with COVID-19, ALI is predominantly due to large or medium artery thrombosis and embolism, although other etiologies can also occur. As with ALI in the general population, the lower extremity is affected more commonly than the upper extremity [<a href="#rid11">11-13,19,20</a>]. In the largest case series, which included 42 patients with ALI, the distribution of ischemic events included [<a href="#rid12">12</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Lower extremity – 71 percent </p><p class="bulletIndent1"><span class="glyph">●</span>Upper extremity – 14 percent </p><p class="bulletIndent1"><span class="glyph">●</span>Cerebral ischemia – 10 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Bowel ischemia – 4 percent </p><p class="bulletIndent1"><span class="glyph">●</span>Multiple locations occurred – 12 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Concomitant deep vein thrombosis – 16 percent </p><p></p><p class="headingAnchor" id="H2984032167"><span class="h2">Patient characteristics</span><span class="headingEndMark"> — </span>Based on several case series  (<a class="graphic graphic_table graphicRef129831" href="/d/graphic/129831.html" rel="external">table 1</a>), patients with COVID-19 associated ALI were, on average, over 60 years of age with body mass index &gt;25 and had typical cardiovascular risk factors including hypertension, PAD, and diabetes [<a href="#rid12">12,13,19-21</a>]. Several meta-analyses reported higher prevalence of ALI in men [<a href="#rid15">15,22</a>]. The incidence of PAD and diabetes in these reviews has varied, ranging from 4 to 37.6 and 15 to 53 percent, respectively. It is important to note that COVID-19 associated ALI can occur in young, otherwise healthy individuals. About 20 percent of patients are young with no significant medical history and do not exhibit typical risk factors for arterial disease. This observation is based on several case reports and small case series, but there are no large, population-based studies to confirm it [<a href="#rid23">23-28</a>].</p><p>In a review of cases from a New York hospital, the median age for hospitalized patients with ALI was 64 [<a href="#rid21">21</a>]. On multivariate analysis, age, male sex, Hispanic ethnicity, history of myocardial infarction, coronary artery disease, and elevated D-dimer level at hospital presentation were significantly associated with an increased risk of developing an arterial thrombotic event leading to stroke, myocardial infarction, ALI, or acute mesenteric ischemia. The risk was highest in patients ≥75 years of age (hazard ratio 2.71, 95% CI 1.65-4.43). </p><p>Several retrospective studies from France and Italy reported a similar incidence of COVID-19 associated ALI (0.6 to 2.4 percent) in patients receiving thromboprophylaxis or therapeutic anticoagulation [<a href="#rid20">20,29,30</a>]. In contrast, a randomized control trial conducted in 34 centers in the United States showed that full-dose anticoagulation reduced thrombotic complications as compared with standard-dose prophylactic anticoagulation [<a href="#rid31">31</a>].</p><p>ALI can develop in those without typical risk factors for thrombosis. None of four patients in one review had any history of thromboembolism or risk factors that could justify their ischemia [<a href="#rid32">32</a>]. Three patients developed unsalvageable lower limb ischemia due to partial to complete occlusion of infrarenal aorta. Another developed acute upper limb ischemia due to complete occlusion of the axillary and brachial artery. </p><p class="headingAnchor" id="H1685778155"><span class="h1">CLINICAL PRESENTATIONS AND DIAGNOSIS</span><span class="headingEndMark"> — </span>ALI is defined as an acute decrease in limb perfusion, usually producing new or worsening symptoms or signs, and often threatening limb viability. The classic clinical features of ALI include the 6 Ps (pain, pallor, poikilothermia, pulselessness, paresthesia, and paralysis). A detailed discussion of the clinical examination is provided separately. (See  <a class="medical medical_review" href="/d/html/8213.html" rel="external">"Clinical features and diagnosis of acute lower extremity ischemia", section on 'Six Ps'</a> and  <a class="medical medical_review" href="/d/html/118660.html" rel="external">"Overview of upper extremity ischemia", section on 'Six Ps of acute ischemia'</a>.)</p><p>The presence and degree of sensorimotor deficits and Doppler findings determine the severity of ALI as described by the Society for Vascular Surgery/International Society for Clinical Vascular Surgery (SVS/ISCVS; ie, Rutherford) classification ranging from a viable, not immediately threatened limb (stage I) to a profoundly ischemic limb with irreversible damage (stage III) [<a href="#rid33">33-36</a>]. The severity of ALI determines the urgency and type of diagnostic evaluation and course of treatment. (See <a class="local">'Diagnostic evaluation'</a> below and <a class="local">'Approach to limb management'</a> below.)</p><p class="headingAnchor" id="H3751446417"><span class="h2">Acute limb ischemia presentations</span><span class="headingEndMark"> — </span>While ALI is a complication of hospitalized patients with severe COVID-19, it can occur in patients with mild symptoms of COVID-19, and moreover ALI can be the primary presenting symptom of COVID-19 even in the absence of respiratory symptoms [<a href="#rid11">11-13,19-21</a>]  (<a class="graphic graphic_table graphicRef129831" href="/d/graphic/129831.html" rel="external">table 1</a>). In addition, ALI can occur concurrently with ischemic symptoms in other vascular beds (arterial, venous) and has also been reported in association with vaccine-induced immune thrombocytopenia and thrombosis (VITT). Some studies described that 12 to 18 percent of patients developed thrombosis in multiple arterial locations, including extremities, visceral, cerebral, and coronary arteries [<a href="#rid12">12,15,25,26,37</a>]. In another study, 16 percent of patients with ALI also had a concomitant deep vein thrombosis [<a href="#rid38">38</a>].</p><p class="headingAnchor" id="H3748975342"><span class="h3">ALI with mild or no symptoms of COVID-19</span><span class="headingEndMark"> — </span>Infected patients with minimal or no symptoms of COVID-19 can develop a prothrombotic state, and reports have described patients complaining predominantly of acute extremity pain that was associated with mild respiratory symptoms or other symptoms associated with COVID-19, but in some cases ALI has been the sole clinical manifestation of COVID-19 [<a href="#rid12">12,23,39-53</a>]. ALI has also been described following recovery from a mild cases of COVID-19 [<a href="#rid37">37,54,55</a>]. </p><p>In a review of 49 patients of COVID-19-associated ALI, acute arterial ischemia was the initial presentation in 22 (45 percent) patients; COVID-19 was subsequently diagnosed on laboratory testing [<a href="#rid12">12</a>]. In a review from Italy, among patients presenting to the emergency room with ALI, 15 of 32 patients were positive for COVID-19 on admission or shortly thereafter [<a href="#rid56">56</a>]. </p><p class="headingAnchor" id="H3290609892"><span class="h3">ALI in hospitalized patients</span><span class="headingEndMark"> — </span>Among hospitalized patients, case reports and case series describe the occurrence of ALI at variable times during the hospitalization, either as isolated large/medium vessel thrombosis or concurrently with thrombosis in other vascular beds (arterial or venous) [<a href="#rid12">12,57-60</a>], but often heralded by increasing D-dimer levels [<a href="#rid11">11,13,23,61-69</a>]. Thrombosis of large (eg, aorta, iliac, subclavian, axillary) and medium-sized (superficial femoral, brachial) arteries of the upper and lower extremities are more commonly reported compared with other arterial sites (see <a class="local">'Etiology and anatomic distribution'</a> above) [<a href="#rid32">32,70-81</a>]. Thrombosis of prior vascular reconstruction including stents and bypass grafts have also been reported [<a href="#rid82">82,83</a>].</p><p>Among 49 patients diagnosed with COVID-19 related ALI, 27 (55 percent) developed ischemia during hospitalization [<a href="#rid12">12</a>]. In a retrospective review of all adult patients with a confirmed diagnosis of COVID-19 admitted to a tertiary care hospital over a three-month period, 6 of 638 (0.9 percent; median age 62 years) developed ALI, all of whom were receiving low-molecular-weight heparin when ALI developed [<a href="#rid61">61</a>]. The median of duration between COVID-19 diagnosis and ALI symptom onset was 13 days. In another review, thrombotic events in the setting of COVID-19 infection occurred at a median of 11 (5 to 20) days after the first symptoms of infection [<a href="#rid11">11</a>]. </p><p>As with other critically ill patients, patients with COVID-19 may be treated with multiple vasopressor agents that can lead to small vessel thrombosis, acral ischemia, and digital gangrene (upper or lower extremities) [<a href="#rid84">84-86</a>]. </p><p class="headingAnchor" id="H2155486411"><span class="h3">ALI following vaccination</span><span class="headingEndMark"> — </span>VITT is an extremely highly morbid but rare condition that has occurred following two adenoviral vector-based vaccines: the ChadOx1 nCoV-19/AZD1222 (AstraZeneca COVID-19 vaccine) and Ad26.COV2.S (<a class="drug drug_general" data-topicid="130461" href="/d/drug information/130461.html" rel="external">Janssen COVID-19 vaccine</a>, also referred to as the Johnson &amp; Johnson vaccine) [<a href="#rid87">87-91</a>]. The risk for developing thrombosis associated with these vaccines, clinical features, and diagnosis are reviewed separately. (See  <a class="medical medical_review" href="/d/html/131333.html" rel="external">"COVID-19: Vaccine-induced immune thrombotic thrombocytopenia (VITT)", section on 'Epidemiology'</a> and  <a class="medical medical_review" href="/d/html/131333.html" rel="external">"COVID-19: Vaccine-induced immune thrombotic thrombocytopenia (VITT)", section on 'Clinical features'</a>.) </p><p>Venous thrombosis, and more rarely arterial thrombosis leading to ALI, has been reported. In a review of 170 definite and 50 probable cases of VITT, while cerebral vein thrombosis and deep venous thrombosis were most common, acute limb ischemia occurred in 26 patients (12 percent) of patients [<a href="#rid87">87</a>]. </p><p class="headingAnchor" id="H2177216358"><span class="h2">Diagnostic evaluation</span><span class="headingEndMark"> — </span>Because arterial thrombosis can occur without the traditional risk factors associated with ALI, a high index of suspicion is necessary to recognize evolving ALI and to provide early, directed treatment, as indicated. The diagnosis of ALI is predominantly clinical based on physical examination findings, including measurement of extremity pressures (eg, ankle brachial index, wrist brachial index, if distal Doppler signals are present), in combination with the patient's history. Vascular imaging confirms the location and extent of arterial obstruction and aids with planning intervention. (See  <a class="medical medical_review" href="/d/html/8213.html" rel="external">"Clinical features and diagnosis of acute lower extremity ischemia", section on 'Diagnosis'</a> and  <a class="medical medical_review" href="/d/html/118660.html" rel="external">"Overview of upper extremity ischemia", section on 'Diagnosis'</a>.)</p><p>Duplex ultrasound and CT angiography are the most common confirmatory imaging modalities and help determine the anatomic location and extent of the arterial occlusion. CT angiography can be useful for identifying a proximal thromboembolic source [<a href="#rid65">65</a>]. The European Society for Vascular Surgery 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischemia in Light of the COVID-19 Pandemic recommend imaging with CT angiography from the aortic arch to the feet/hands in these patients [<a href="#rid92">92</a>]. This allows for exclusion of other thrombotic events that have been often reported to occur in combination with ALI. However, in the setting of the COVID-19 pandemic, the vascular imaging study used has depended upon the stability of the patient for transfer to the imaging suite, if needed, as well as consideration for allocation of resources. In a review of a small cohort of 16 patients with acute upper or lower extremity ischemia, only 8 patients underwent confirmatory imaging studies [<a href="#rid20">20</a>]. In general, for patients with viable or marginally threatened limbs, there is usually enough time to obtain vascular imaging prior to intervention. However, patients with an immediately threatened limb require more urgent evaluation, typically in an operating room setting. (See <a class="local">'Approach to limb management'</a> below.)</p><p>Obtaining a platelet count, D-dimer, fibrinogen, and the use of thromboelastography can be helpful for assessing the degree of hypercoagulability [<a href="#rid3">3,93,94</a>]. In critically ill patients, D-dimer, fibrinogen, and factor VIII are often elevated, and protein C, protein S, and antithrombin levels are decreased [<a href="#rid95">95,96</a>]. Antiphospholipid antibodies may also be present. The correlation between D-dimer levels and clinical outcomes is not clear. In a retrospective study from China, 46.4 percent of patients with COVID-19 had elevated D-dimer, and the elevation was more pronounced in severe cases [<a href="#rid97">97</a>]. Several studies have reported that increased D-dimer levels were significantly associated with increased mortality [<a href="#rid3">3,93,98-100</a>]. In a review of 183 patients with COVID-19, 21 (11.5 percent) patients died; 71 percent of patients who died had coagulation abnormalities compared with 0.6 percent of survivors [<a href="#rid99">99</a>]. However, a later meta-analysis that included 34 studies showed that increased D-dimer levels were not associated with death (odds ratio [OR] 1.17, 95% CI 0.36-3.76) or amputation (OR 2.0, 95% CI 0.33-11.97) [<a href="#rid22">22</a>]. Increasing D-dimer in hospitalized patients may also herald the occurrence of thrombotic events [<a href="#rid11">11,101</a>]. Other common laboratory abnormalities in patients with COVID-19 include lymphopenia, elevated lactate dehydrogenase, and increases in inflammatory markers such as C-reactive protein, ferritin, and interleukin-6. </p><p class="headingAnchor" id="H2954894075"><span class="h2">Differential diagnosis</span><span class="headingEndMark"> — </span>The differential diagnosis of ALI in patients with COVID-19 includes other conditions that present with extremity pain or neurologic abnormalities and conditions that mimic the appearance of ischemia, which may or may not be associated with COVID-19. (See  <a class="medical medical_review" href="/d/html/8213.html" rel="external">"Clinical features and diagnosis of acute lower extremity ischemia", section on 'Differential diagnosis'</a> and  <a class="medical medical_review" href="/d/html/118660.html" rel="external">"Overview of upper extremity ischemia", section on 'Differential diagnosis'</a>.)</p><p>Dermatologic conditions associated with COVID-19 are increasingly recognized [<a href="#rid102">102,103</a>] and these may mimic the appearance of ischemia (eg, acute chilblains). (See  <a class="medical medical_review" href="/d/html/127978.html" rel="external">"COVID-19: Cutaneous manifestations and issues related to dermatologic care"</a>.)</p><p class="headingAnchor" id="H2466851343"><span class="h1">MANAGEMENT</span><span class="headingEndMark"> — </span>Timely vascular surgery consultation is critical in the management of patients with COVID-19 associated ALI [<a href="#rid13">13,104</a>].</p><p class="headingAnchor" id="H862015200"><span class="h2">Initiate anticoagulation</span><span class="headingEndMark"> — </span>For patients with ALI, we initiate therapeutic anticoagulation with intravenous <a class="drug drug_general" data-topicid="8518" href="/d/drug information/8518.html" rel="external">unfractionated heparin</a> (bolus followed by continuous infusion), which should be provided once a diagnosis of ALI is established, unless there are significant contraindications such as active or serious bleeding in the prior 24 to 48 hours, recent surgery, or contraindications to the use of heparin (eg, history of heparin-induced thrombocytopenia [HIT] or suspected HIT). There are no data to suggest superiority of any type of anticoagulant, such as unfractionated heparin, low molecular weight heparin, or oral anticoagulants [<a href="#rid105">105</a>]. (See  <a class="medical medical_review" href="/d/html/127926.html" rel="external">"COVID-19: Hypercoagulability", section on 'Resources and other guidance'</a>.)</p><p>It is important to recognize that patients with COVID-19 can have a variety of abnormal coagulation patterns that may inhibit adequate therapeutic anticoagulation.</p><p class="bulletIndent1"><span class="glyph">●</span>Heparin resistance, which is overall rare, has been observed [<a href="#rid101">101</a>]. Heparin resistance is defined as failure to achieve the desired activated clotting time after a full dose, or the need for high-dose <a class="drug drug_general" data-topicid="8518" href="/d/drug information/8518.html" rel="external">unfractionated heparin</a> of more than 35,000 international units/day to achieve the target-activated partial-thromboplastin time ratio [<a href="#rid106">106-108</a>]. (See  <a class="medical medical_review" href="/d/html/1348.html" rel="external">"Heparin and LMW heparin: Dosing and adverse effects", section on 'Heparin resistance/antithrombin deficiency'</a> and  <a class="medical medical_review" href="/d/html/1360.html" rel="external">"Antithrombin deficiency"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>HIT has also been reported in patients with COVID-19 [<a href="#rid109">109,110</a>]. (See  <a class="medical medical_review" href="/d/html/118004.html" rel="external">"Management of heparin-induced thrombocytopenia (HIT) during cardiac or vascular surgery"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>New thromboembolic events have occurred despite apparently adequate anticoagulation in patients with COVID-19 [<a href="#rid104">104</a>].</p><p></p><p class="headingAnchor" id="H2427683368"><span class="h2">Approach to limb management</span><span class="headingEndMark"> — </span>Limb viability is classified and managed using the Society for Vascular Surgery/International Society for Clinical Vascular Surgery (Rutherford) classification [<a href="#rid34">34-36,111</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span>Marginally threatened limbs (class IIa) are salvageable if treated promptly. There is minimal pain and minimal (toes only) or no sensory loss, and no muscle weakness; arterial Doppler signals are often inaudible, but venous Doppler signals are audible. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Immediately threatened limbs (class IIb) are salvageable with immediate revascularization. Sensory loss involves more than the toes and may be associated with rest pain in the foot (not just confined to toes). There is mild-to-moderate muscle weakness, arterial Doppler signals are usually inaudible, and venous Doppler signals are audible.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Irreversible ischemic (nonviable; class III) limbs have a severe and permanent nerve deficit. Sensory loss is profound, muscle weakness is profound with paralysis and possible rigor, and arterial and venous Doppler signals are inaudible. If the affected limb is nonviable at presentation, primary amputation will be required. </p><p></p><p>Based on the patient's overall stability, degree of ischemia, and limb viability, a determination needs to be made whether intervention is appropriate, and if so, whether an endovascular or open approach should be used. It is crucial to consider the severity of systemic illness when considering intervention. Because of the severe pulmonary complications associated with COVID-19, critically ill patients may not be candidates for revascularization. Similar to damage control in trauma patients, the principle of "life over limb" is justified. Based on published case series, less than half of patients with COVID-19 associated ALI underwent attempts at limb salvage; up to 15 percent required primary amputation  (<a class="graphic graphic_table graphicRef129831" href="/d/graphic/129831.html" rel="external">table 1</a>). In one series of 49 patients, revascularization was performed in 13 (27 percent) patients, primary amputation in 5 (10 percent), 28 (57 percent) were treated with systemic anticoagulation only, and 3 (6 percent) received systemic administration of tissue-plasminogen activator [<a href="#rid12">12</a>]. The rate of limb loss was 18 percent. Twenty-one patients (46 percent) died in the hospital. In a systematic review that included 199 patients, 58 percent underwent revascularization procedures with a 23 percent pooled amputation rate and 31 percent pooled mortality rate [<a href="#rid22">22</a>]</p><p class="headingAnchor" id="H634756220"><span class="h1">VASCULAR INTERVENTION</span></p><p class="headingAnchor" id="H3808414508"><span class="h2">Options for revascularization</span><span class="headingEndMark"> — </span>Options for revascularization include the following: </p><p class="bulletIndent1"><span class="glyph">●</span>Surgical revascularization for ALI consists of open thrombectomy, although other adjuncts may be required, including endarterectomy/patch angioplasty and/or surgical bypass. (See  <a class="medical medical_review" href="/d/html/15194.html" rel="external">"Lower extremity surgical bypass techniques"</a> and  <a class="medical medical_review" href="/d/html/16939.html" rel="external">"Surgical and endovascular techniques for aortic arch branch and upper extremity revascularization"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Endovascular revascularization may include catheter-directed thrombolysis or percutaneous mechanical thrombectomy. (See  <a class="medical medical_review" href="/d/html/15218.html" rel="external">"Intra-arterial thrombolytic therapy for the management of acute limb ischemia"</a> and  <a class="medical medical_review" href="/d/html/15217.html" rel="external">"Endovascular techniques for lower extremity revascularization"</a> and  <a class="medical medical_review" href="/d/html/16939.html" rel="external">"Surgical and endovascular techniques for aortic arch branch and upper extremity revascularization"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>At times, a combination of open and endovascular techniques may be needed. As an example, in a case of ALI due to extensive thrombosis of an aortic aneurysm, iliac arteries, and infrainguinal arteries, thrombolytic therapy restored patency of the aortoiliac occlusion, and bilateral open thrombectomy of the infrainguinal vessels restored distal perfusion [<a href="#rid80">80</a>].</p><p></p><p>There are no high-quality data to inform the choice for open versus endovascular intervention for COVID-19 associated ALI. Both have been associated with successful limb salvage, and both have also been associated with high rates of mortality and morbidity. The choice is likely influenced by specific anatomic considerations (eg, presence of atherosclerotic plaque, aneurysm), operator preference, and institutional resources.</p><p class="headingAnchor" id="H2901935518"><span class="h2">Postprocedural anticoagulation</span><span class="headingEndMark"> — </span>Following intervention for ALI, based on general treatment outcomes in patients with ALI, patients with COVID-19 should be maintained on therapeutic anticoagulation and transitioned to oral anticoagulation (eg, <a class="drug drug_general" data-topicid="10050" href="/d/drug information/10050.html" rel="external">warfarin</a>, direct oral anticoagulants [DOACs], or low molecular weight heparin, with or without an antiplatelet agent [eg, <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a>]). Oral anticoagulation is an established therapy following intervention for ALI with subsequent reduction in recurrent ischemic limb events and amputation [<a href="#rid112">112</a>]. </p><p>Data specific to postprocedural anticoagulation in patients with COVID-19 associated ALI are sparse. In one Italian review, 17 of 20 patients with ALI underwent revascularization, which was successful in 12 patients [<a href="#rid13">13</a>]. While successful revascularization was not significantly associated with the postoperative use of intravenous heparin, no patient who received postoperative anticoagulation required reintervention. Two patients required reintervention because of a recurrent thrombotic occlusion within the first 48 hours. The use of continuous postoperative heparin was associated with increased survival. The authors concluded that prolonged systemic heparin might improve surgical treatment efficacy, limb salvage, and overall survival. Additional data on anticoagulation management for COVID-19 related ALI are anticipated [<a href="#rid113">113</a>]. </p><p class="headingAnchor" id="H741379758"><span class="h1">LIMB OUTCOMES AND MORTALITY</span><span class="headingEndMark"> — </span>Overall, the mortality rate of COVID-19 for those who require hospitalization is over 20 percent [<a href="#rid114">114</a>]. In most cases, the cause of death has been attributed to respiratory failure, sepsis, cardiac failure, kidney injury, or the consequences of coagulation abnormalities [<a href="#rid115">115</a>]. Among patients who develop ALI, mortality rates are as high as 50 percent  (<a class="graphic graphic_table graphicRef129831" href="/d/graphic/129831.html" rel="external">table 1</a>) [<a href="#rid13">13,19,20</a>]. In a review of 571 COVID-19 patients, the risk of death was nearly three-fold higher in patients who had arterial thrombotic events (hazard ratio 2.96, 95% CI 1.4-4.7) [<a href="#rid11">11</a>]. A meta-analysis of 11 studies showed a significantly higher probability of death in COVID-19 patients with ALI compared with nonCOVID-19 patients with ALI (odds ratio [OR] 4.71, 95% CI 1.11-19.99) with an overall mortality rate of 33 percent in ALI patients who were COVID-19 positive [<a href="#rid116">116</a>].</p><p class="headingAnchor" id="H3437618093"><span class="h2">Amputation</span><span class="headingEndMark"> — </span>The rate of major amputation (eg, below-knee amputation, above-knee amputation) is higher than that associated with other vascular conditions and is required in 7 to 35 percent of patients with COVID-19 associated ALI  (<a class="graphic graphic_table graphicRef129831" href="/d/graphic/129831.html" rel="external">table 1</a>) [<a href="#rid12">12,13,19,20</a>]. In the general population, in the absence of COVID-19, rates of major amputation following intervention for ALI are between 6 and 23 percent, depending on etiology and comorbidities [<a href="#rid117">117-119</a>]. As examples, in a single-institution series of 74 patients with ALI and cancer, the amputation rate was 11 percent [<a href="#rid120">120</a>]. In a pharmacologic trial that included patients with symptomatic peripheral artery disease, the rate of major amputation in those who developed ALI was 16 percent [<a href="#rid117">117</a>]. In addition, because patients with COVID-19 are commonly severely deconditioned from often prolonged illness with COVID-19, recovery and rehabilitation following amputation may be prolonged. </p><p class="headingAnchor" id="H1740894252"><span class="h2">Recurrent arterial thrombosis</span><span class="headingEndMark"> — </span>Some patients with COVID-19 related acute limb ischemia develop recurrent thrombosis after invasive interventions (eg, thrombectomy, thrombolysis) that were initially technically successful. One review reported a 17 percent rate of rethrombosis after revascularization in patients with COVID-19, with a significantly higher probability of rethrombosis as compared with a patient without COVID-19 (OR 2.65, 95% CI 1.34-5.23) [<a href="#rid116">116</a>]. There have been reported cases of successful limb salvage following recurrent arterial thrombosis. In some cases, the patient's clinical condition may have deteriorated such that further attempts to salvage the limb are no longer feasible. For others, the inability to clear outflow vessels may severely limit any meaningful attempt at salvage, and limb amputation may become a necessary lifesaving procedure [<a href="#rid24">24</a>]. In either case, limb amputation may become a necessary lifesaving procedure. </p><p class="headingAnchor" id="H2665962195"><span class="h1">RESEARCH INITIATIVES</span><span class="headingEndMark"> — </span>There is an need for high-quality research on the impact of COVID-19 on patients with preexisting vascular disease, those with COVID-19 related vasculopathy, and delivery of care [<a href="#rid121">121</a>].<sup> </sup>The Vascular Surgery COVID-19 Collaborative (VASCC) is an international registry collecting deidentified patient data from a wide variety of clinical practices with the aim of evaluating the effects of COVID-19 on vascular practice patterns as well as studying vascular manifestations and outcomes in patients with COVID-19 [<a href="#rid122">122,123</a>]. Ongoing research regarding the thrombotic vascular complications of COVID-19 aims to: </p><p class="bulletIndent1"><span class="glyph">●</span>Identify key components of the diagnostic work-up</p><p class="bulletIndent1"><span class="glyph">●</span>Describe surgical, endovascular, and non-operative management</p><p class="bulletIndent1"><span class="glyph">●</span>Investigate various perioperative and postoperative anticoagulation strategies </p><p></p><p class="headingAnchor" id="H2991503722"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/126613.html" rel="external">"Society guideline links: COVID-19 – Index of guideline topics"</a>.)</p><p class="headingAnchor" id="H914901057"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/126678.html" rel="external">"Patient education: COVID-19 overview (The Basics)"</a> and  <a class="medical medical_basics" href="/d/html/127758.html" rel="external">"Patient education: COVID-19 and pregnancy (The Basics)"</a> and  <a class="medical medical_basics" href="/d/html/127544.html" rel="external">"Patient education: COVID-19 and children (The Basics)"</a> and  <a class="medical medical_review" href="/d/html/129849.html" rel="external">"COVID-19: Vaccines"</a> and  <a class="medical medical_basics" href="/d/html/130329.html" rel="external">"Patient education: COVID-19 vaccines (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H3877410474"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acute limb ischemia</strong> – Thrombotic complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection present in a variety of ways. Acute limb ischemia (ALI), the sudden decrease in perfusion to an extremity, is a dramatic clinical event more typically reported in association with severe infection; however, it has been reported in patients with few or none of the respiratory symptoms associated with coronavirus disease 2019 (COVID-19). While ALI can occur due to embolic or thrombotic etiologies, a thrombotic etiology predominates in patients with COVID-19. (See <a class="local">'Incidence and distribution'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features of ALI associated with COVID-19</strong> – The classic clinical features of ALI include the 6 Ps (pain, pallor, poikilothermia, pulselessness, paresthesia, and paralysis). Clinical features of COVID-19 associated ALI include the following (see <a class="local">'Clinical presentations and diagnosis'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The lower extremity is affected more commonly (about 70 percent) compared with the upper extremity. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Risk factors for ALI in patients with COVID-19 infection include older age, obesity, and cardiovascular comorbidities.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients without risk factors can develop ALI.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>ALI can develop in patients with COVID-19 even when receiving thromboprophylaxis.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Elevated D-dimer levels occur in most patients who develop ALI, and a sudden increase in D-dimer may herald the acute thrombotic event. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>ALI more typically affects patients with severe COVID-19, occurring five to seven days after respiratory decompensation.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>About 20 percent of patients who present with COVID-19 related ALI have few or no respiratory symptoms. Furthermore, ALI can occur during the recovery phase following infection of any severity.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Thrombosis of large (eg, aorta, iliac, subclavian, axillary) or medium-sized (eg, superficial femoral, brachial, tibial) arteries have all been reported. Small vessel thrombosis leading to digital gangrene is often associated with the administration of vasopressor agents. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Thrombosis of prior vascular reconstruction including stents and bypass grafts can also occur.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnostic evaluation</strong> – The diagnosis of ALI is predominantly clinical, and vascular imaging (duplex ultrasound, computed tomographic angiography) confirms the location and extent of arterial obstruction. The selection of vascular imaging studies in patients with COVID-19 associated ALI may be dictated by available resources and the stability of the patient to undergo the study. Limb viability is classified by the Society for Vascular Surgery/International Society for Clinical Vascular Surgery (ie, Rutherford) classification based upon the presence and degree of sensorimotor deficits and Doppler findings. The severity of ALI determines the urgency and type of diagnostic evaluation and course of treatment. (See <a class="local">'Diagnostic evaluation'</a> above and <a class="local">'Management'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anticoagulation</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Therapeutic anticoagulation should be initiated once a diagnosis of ALI is established. Patients with COVID-19 can have a variety of abnormal coagulation patterns that may inhibit adequate therapeutic anticoagulation such as heparin resistance or heparin-induced thrombocytopenia. Thromboembolic events can occur despite apparently adequate anticoagulation. (See <a class="local">'Initiate anticoagulation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Following successful intervention for ALI (endovascular, surgical), patients with COVID-19 are maintained on therapeutic anticoagulation and transitioned to oral anticoagulation (eg, <a class="drug drug_general" data-topicid="10050" href="/d/drug information/10050.html" rel="external">warfarin</a>, direct oral anticoagulants [DOACs] or low molecular weight heparin, with or without the addition of an antiplatelet agent [eg, <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a>]) to reduce the incidence of recurrent ischemic events. (See <a class="local">'Postprocedural anticoagulation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vascular intervention</strong> – It is important to consider the severity of systemic illness when considering whether to perform an intervention in patients with COVID-19. Many patients with severe respiratory manifestations of COVID-19 are not candidates for limb salvage. Despite attempts at revascularization (endovascular, open surgical), ALI associated with COVID-19 has high mortality and high rates of limb loss. Major amputation (eg, below-knee amputation, above-knee amputation) is required in up to a third of patients. (See <a class="local">'Vascular intervention'</a> above and <a class="local">'Limb outcomes and mortality'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Violi F, Pastori D, Cangemi R, et al. Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge. Thromb Haemost 2020; 120:949.</a></li><li><a class="nounderline abstract_t">Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol 2020; 127:104362.</a></li><li><a class="nounderline abstract_t">Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID-19. Am J Hematol 2020; 95:834.</a></li><li><a class="nounderline abstract_t">Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol 2020; 75:2950.</a></li><li><a class="nounderline abstract_t">Singh S, Zuwasti U, Haas C. Coronavirus-Associated Coagulopathy: Lessons From SARS-CoV1 and MERS-CoV for the Current SARS-CoV2 Pandemic. Cureus 2020; 12:e11310.</a></li><li><a class="nounderline abstract_t">Wu YP, Wei R, Liu ZH, et al. Analysis of thrombotic factors in severe acute respiratory syndrome (SARS) patients. Thromb Haemost 2006; 96:100.</a></li><li><a class="nounderline abstract_t">Ng JJ, Choong AMTL. Thromboembolic events in patients with SARS-CoV-2. J Vasc Surg 2020; 72:760.</a></li><li><a class="nounderline abstract_t">Ilonzo N, Judelson D, Al-Jundi W, et al. A review of acute limb ischemia in COVID-positive patients. Semin Vasc Surg 2021; 34:8.</a></li><li class="breakAll">Labò N, Ohnuki H, Tosato G. Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection. Cells. 2020; 9:1583.</li><li><a class="nounderline abstract_t">Griffin DO, Jensen A, Khan M, et al. Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease. Emerg Infect Dis 2020; 26:1941.</a></li><li><a class="nounderline abstract_t">Fournier M, Faille D, Dossier A, et al. Arterial Thrombotic Events in Adult Inpatients With COVID-19. Mayo Clin Proc 2021; 96:295.</a></li><li><a class="nounderline abstract_t">Etkin Y, Conway AM, Silpe J, et al. Acute Arterial Thromboembolism in Patients with COVID-19 in the New York City Area. Ann Vasc Surg 2021; 70:290.</a></li><li><a class="nounderline abstract_t">Bellosta R, Luzzani L, Natalini G, et al. Acute limb ischemia in patients with COVID-19 pneumonia. J Vasc Surg 2020; 72:1864.</a></li><li><a class="nounderline abstract_t">Candeloro M, Schulman S. Arterial Thrombotic Events in Hospitalized COVID-19 Patients: A Short Review and Meta-Analysis. Semin Thromb Hemost 2023; 49:47.</a></li><li><a class="nounderline abstract_t">Cheruiyot I, Kipkorir V, Ngure B, et al. Arterial Thrombosis in Coronavirus Disease 2019 Patients: A Rapid Systematic Review. Ann Vasc Surg 2021; 70:273.</a></li><li><a class="nounderline abstract_t">Howard DP, Banerjee A, Fairhead JF, et al. Population-Based Study of Incidence, Risk Factors, Outcome, and Prognosis of Ischemic Peripheral Arterial Events: Implications for Prevention. Circulation 2015; 132:1805.</a></li><li><a class="nounderline abstract_t">Hess CN, Huang Z, Patel MR, et al. Acute Limb Ischemia in Peripheral Artery Disease. Circulation 2019; 140:556.</a></li><li><a class="nounderline abstract_t">Bonaca MP, Bauersachs RM, Anand SS, et al. Rivaroxaban in Peripheral Artery Disease after Revascularization. N Engl J Med 2020; 382:1994.</a></li><li class="breakAll">Indes JE, Koleilat I, Hatch AN, et al. Early Experience with Arterial Thromboembolic Complications in Patents with COVID-19. J Vasc Surg 2020; S0741.</li><li class="breakAll">Llonzo N, Rao A, Safir S, Vouyouka A, Phair J, Baldwin M, et al. Acute Thrombotic Manifestation of COVID-19 Infection: Experience at a Large New York city Health System. J Vasc Surg 2020; S0741.</li><li><a class="nounderline abstract_t">Bilaloglu S, Aphinyanaphongs Y, Jones S, et al. Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System. JAMA 2020; 324:799.</a></li><li><a class="nounderline abstract_t">Galyfos G, Sianou A, Frountzas M, et al. Acute limb ischemia among patients with COVID-19 infection. J Vasc Surg 2022; 75:326.</a></li><li><a class="nounderline abstract_t">Wengerter SP, Wengerter KR, Masoudpoor H, et al. Acute aortoiliac and infrainguinal arterial thrombotic events in four patients diagnosed with the novel coronavirus 2019. J Vasc Surg Cases Innov Tech 2020; 6:698.</a></li><li><a class="nounderline abstract_t">Ramachandran R, Vasudevan Pillai A, Raja S, Sailesh S. Axillary artery thrombosis resulting in upper limb amputation as a COVID-19 sequela. BMJ Case Rep 2021; 14.</a></li><li><a class="nounderline abstract_t">Mestres G, Puigmacià R, Blanco C, et al. Risk of peripheral arterial thrombosis in COVID-19. J Vasc Surg 2020; 72:756.</a></li><li><a class="nounderline abstract_t">Narvaneni S, Fasulo SM, Kumar V, et al. COVID-19 Induced Bilateral Lower Limb Ischemia and Visceral Infarcts. Cureus 2021; 13:e12784.</a></li><li><a class="nounderline abstract_t">Perini P, Nabulsi B, Massoni CB, et al. Acute limb ischaemia in two young, non-atherosclerotic patients with COVID-19. Lancet 2020; 395:1546.</a></li><li><a class="nounderline abstract_t">Al-Zoubi N, Shatnawi N, Jarbo H. Acute Lower Limb Ischemia in Patients Infected with COVID-19. Int J Gen Med 2021; 14:833.</a></li><li><a class="nounderline abstract_t">Fraissé M, Logre E, Pajot O, et al. Thrombotic and hemorrhagic events in critically ill COVID-19 patients: a French monocenter retrospective study. Crit Care 2020; 24:275.</a></li><li><a class="nounderline abstract_t">Goldman IA, Ye K, Scheinfeld MH. Lower-extremity Arterial Thrombosis Associated with COVID-19 Is Characterized by Greater Thrombus Burden and Increased Rate of Amputation and Death. Radiology 2020; 297:E263.</a></li><li><a class="nounderline abstract_t">Bohula EA, Berg DD, Lopes MS, et al. Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT. Circulation 2022; 146:1344.</a></li><li><a class="nounderline abstract_t">Lari E, Lari A, AlQinai S, et al. Severe ischemic complications in Covid-19-A case series. Int J Surg Case Rep 2020; 75:131.</a></li><li><a class="nounderline abstract_t">Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017; 69:e71.</a></li><li><a class="nounderline abstract_t">Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997; 26:517.</a></li><li><a class="nounderline abstract_t">Katzen BT. Clinical diagnosis and prognosis of acute limb ischemia. Rev Cardiovasc Med 2002; 3 Suppl 2:S2.</a></li><li><a class="nounderline abstract_t">Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113:e463.</a></li><li><a class="nounderline abstract_t">Veerasuri S, Kulkarni SR, Wilson WR, Paravastu SCV. Bilateral Acute Lower Limb Ischemia Secondary to COVID-19. Vasc Endovascular Surg 2021; 55:196.</a></li><li><a class="nounderline abstract_t">de Roquetaillade C, Chousterman BG, Tomasoni D, et al. Unusual arterial thrombotic events in Covid-19 patients. Int J Cardiol 2021; 323:281.</a></li><li><a class="nounderline abstract_t">De Hous N, Hollering P, Van Looveren R, et al. Symptomatic arterial thrombosis associated with novel coronavirus disease 2019 (COVID-19): report of two cases. Acta Chir Belg 2023; 123:81.</a></li><li><a class="nounderline abstract_t">Singh B, Aly R, Kaur P, et al. COVID-19 Infection and Arterial Thrombosis: Report of Three Cases. Ann Vasc Surg 2021; 70:314.</a></li><li><a class="nounderline abstract_t">Chiesa R, Kahlberg A, Rinaldi E, Mascia D. Emergency management of the COVID-19 pandemic in a vascular surgery department of a large metropolitan hospital in Italy. Preparation, escalation, de-escalation, and normal activity. J Card Surg 2021; 36:1632.</a></li><li><a class="nounderline abstract_t">Horani G, Kaur K, Patel P, et al. Acute Limb Ischemia as the Initial Severe Presentation in COVID-19. Cureus 2021; 13:e14226.</a></li><li><a class="nounderline abstract_t">Pasqui E, de Donato G, Brancaccio B, et al. Misdiagnosed Acute Limb Ischemia in Three Nonhospitalized Patients Recovering From a Nonsevere COVID-19 Infection. Ann Vasc Surg 2021; 75:140.</a></li><li><a class="nounderline abstract_t">Khryshchanovich VY, Rogovoy NA, Nelipovich EV. Arterial Thrombosis and Acute Limb Ischemia as a Complication of COVID-19 Infection. Am Surg 2023; 89:2046.</a></li><li><a class="nounderline abstract_t">Jolly RD, Thompson KG, Winchester BG. Bovine mannosidosis--a model lysosomal storage disease. Birth Defects Orig Artic Ser 1975; 11:273.</a></li><li><a class="nounderline abstract_t">Mandels M. Microbial sources of cellulase. Biotechnol Bioeng Symp 1975; :81.</a></li><li><a class="nounderline abstract_t">Szeles A, El-Daher NT, Lachant N, Rizk TA. Acute limb ischemia and aortic mural thrombosis as primary manifestations of severe acute respiratory syndrome coronavirus 2. J Vasc Surg Cases Innov Tech 2021; 7:605.</a></li><li><a class="nounderline abstract_t">Maurera AH, Vu JH, Rehring TF, et al. Acute Limb Ischemia in Minimally Symptomatic SARS-CoV-2 Infection. J Vasc Interv Radiol 2020; 31:2150.</a></li><li><a class="nounderline abstract_t">Thompson O, Pierce D, Whang D, et al. Acute limb ischemia as sole initial manifestation of SARS-CoV-2 infection. J Vasc Surg Cases Innov Tech 2020; 6:511.</a></li><li><a class="nounderline abstract_t">Kaur P, Posimreddy S, Singh B, et al. COVID-19 Presenting as Acute Limb Ischaemia. Eur J Case Rep Intern Med 2020; 7:001724.</a></li><li><a class="nounderline abstract_t">Singh B, Kaur P, Ajdir N, et al. Covid-19 Presenting as Acute Limb Ischemia. Cureus 2020; 12:e9344.</a></li><li><a class="nounderline abstract_t">Shao T, In-Bok Lee C, Jabori S, et al. Acute upper limb ischemia as the first manifestation in a patient with COVID-19. J Vasc Surg Cases Innov Tech 2020; 6:674.</a></li><li><a class="nounderline abstract_t">Mietto C, Salice V, Ferraris M, et al. Acute Lower Limb Ischemia as Clinical Presentation of COVID-19 Infection. Ann Vasc Surg 2020; 69:80.</a></li><li><a class="nounderline abstract_t">Borrelli MP, Buora A, Scrivere P, et al. Arterial Thrombotic Sequalae After Covid-19: Mind the Gap. Ann Vasc Surg 2021; 75:128.</a></li><li><a class="nounderline abstract_t">Surya SP, Santoso RM. A clinical case series of COVID-19-associated acute limb ischemia: real-world situation. Egypt Heart J 2021; 73:59.</a></li><li><a class="nounderline abstract_t">Mascia D, Kahlberg A, Melloni A, et al. Single-Center Vascular Hub Experience after 7 weeks of COVID-19 Pandemic in Lombardy (Italy). Ann Vasc Surg 2020; 69:90.</a></li><li><a class="nounderline abstract_t">Berrichi S, Bouayed Z, Berrajaa S, et al. Acute limb ischemia with concomitant splenic and renal infarcts: Thromboembolic events revealing COVID-19. Ann Med Surg (Lond) 2021; 68:102646.</a></li><li><a class="nounderline abstract_t">Brem FL, Abu-Al-Tayef T, Rasras H, et al. Concomitant acute limb ischemia and multiple acute ischemic strokes complicating COVID-19: a case report. Pan Afr Med J 2021; 38:275.</a></li><li><a class="nounderline abstract_t">Madani MH, Leung ANC, Becker HC, et al. Aorto-iliac/right leg arterial thrombosis necessitating limb amputation, pulmonary arterial, intracardiac, and ilio-caval venous thrombosis in a 40-year-old with COVID-19. Clin Imaging 2021; 75:1.</a></li><li><a class="nounderline abstract_t">Dinoto E, Ferlito F, La Marca MA, et al. Staged acute mesenteric and peripheral ischemia treatment in COVID-19 patient: Case report. Int J Surg Case Rep 2021; 84:106105.</a></li><li><a class="nounderline abstract_t">Topcu AC, Ozturk-Altunyurt G, Akman D, et al. Acute Limb Ischemia in Hospitalized COVID-19 Patients. Ann Vasc Surg 2021; 74:88.</a></li><li><a class="nounderline abstract_t">Hasan SA, Haque A, Nazir F. Acute Limb Ischemia: A Rare Complication of COVID-19. Cureus 2020; 12:e11488.</a></li><li><a class="nounderline abstract_t">Sturges S, Brown M. Polypsychopharmacy. Bull Menninger Clin 1975; 39:274.</a></li><li><a class="nounderline abstract_t">Kaur P, Qaqa F, Ramahi A, et al. Acute upper limb ischemia in a patient with COVID-19. Hematol Oncol Stem Cell Ther 2021; 14:348.</a></li><li><a class="nounderline abstract_t">Silingardi R, Gennai S, Migliari M, et al. Acute limb ischemia in COVID-19 patients: Could aortic floating thrombus be the source of embolic complications? J Vasc Surg 2020; 72:1152.</a></li><li><a class="nounderline abstract_t">Bozzani A, Arici V, Tavazzi G, et al. Acute arterial and deep venous thromboembolism in COVID-19 patients: Risk factors and personalized therapy. Surgery 2020; 168:987.</a></li><li><a class="nounderline abstract_t">Sánchez JB, Cuipal Alcalde JD, Ramos Isidro R, et al. Acute Limb Ischemia in a Peruvian Cohort Infected by COVID-19. Ann Vasc Surg 2021; 72:196.</a></li><li><a class="nounderline abstract_t">Putko RM, Bedrin MD, Clark DM, et al. SARS-CoV-2 and limb ischemia: A systematic review. J Clin Orthop Trauma 2021; 12:194.</a></li><li><a class="nounderline abstract_t">Baram A, Kakamad FH, Abdullah HM, et al. Large vessel thrombosis in patient with COVID-19, a case series. Ann Med Surg (Lond) 2020; 60:526.</a></li><li><a class="nounderline abstract_t">Singh B, Kaur P, Patel P, et al. COVID-19 and arterial thrombosis: Report of 2 cases. Radiol Case Rep 2021; 16:1603.</a></li><li><a class="nounderline abstract_t">Nespola M, Sirignano P, Fermani N, et al. Treatment-Resistant Acute Upper Limb Ischemia in a Patient With Systemic Lupus Erythematous and Concomitant SARS-CoV-2 Infection: A Case Report. Ann Vasc Surg 2021; 76:289.</a></li><li><a class="nounderline abstract_t">Burley NB, Dy PS, Kalantri S, Razzaq K. Aortic Thrombosis and Acute Limb Ischemia Secondary to COVID Hypercoagulability. Cureus 2021; 13:e16171.</a></li><li><a class="nounderline abstract_t">Galanis N, Stavraka C, Agathangelidis F, et al. Coagulopathy in COVID-19 infection: a case of acute upper limb ischemia. J Surg Case Rep 2020; 2020:rjaa204.</a></li><li><a class="nounderline abstract_t">Hanif M, Ali MJ, Haider MA, et al. Acute Upper Limb Ischemia Due To Arterial Thrombosis in a Mild COVID-19 Patient: A Case Report. Cureus 2020; 12:e10349.</a></li><li><a class="nounderline abstract_t">Anwar S, Acharya S, Shabih S, Khabut A. Acute Limb Ischemia in COVID-19 Disease: A Mysterious Coagulopathy. Cureus 2020; 12:e9167.</a></li><li><a class="nounderline abstract_t">Ferguson K, Quail N, Kewin P, Blyth KG. COVID-19 associated with extensive pulmonary arterial, intracardiac and peripheral arterial thrombosis. BMJ Case Rep 2020; 13.</a></li><li><a class="nounderline abstract_t">Renaud-Picard B, Gallais F, Ohana M, et al. Bilateral Acute Cardioembolic Limb Ischemia After Coronavirus Disease 2019 Pneumonia in a Lung Transplant Recipient: A Case Report. Transplant Proc 2020; 52:2715.</a></li><li><a class="nounderline abstract_t">Sharma H, George S. Early Left Ventricular Thrombus Formation in a COVID-19 Patient with ST-Elevation Myocardial Infarction. Case Rep Cardiol 2020; 2020:8882463.</a></li><li><a class="nounderline abstract_t">Vacirca A, Faggioli G, Pini R, et al. Unheralded Lower limb threatening ischemia in a COVID-19 patient. Int J Infect Dis 2020; 96:590.</a></li><li><a class="nounderline abstract_t">Patel P, Yu Y, Zia S, et al. Systemic Thrombolysis as Initial Treatment of COVID-19 Associated Acute Aortoiliac and Lower Extremity Arterial Thrombosis. Ann Vasc Surg 2021; 70:297.</a></li><li><a class="nounderline abstract_t">Warrior K, Chung PA, Ahmed N, et al. Acute Limb Ischemia Due to Arterial Thrombosis Associated With Coronavirus Disease 2019. Crit Care Explor 2020; 2:e0140.</a></li><li><a class="nounderline abstract_t">Dinoto E, Ferlito F, Urso F, et al. Mechanical rotational thrombectomy in long femoropopliteal artery and stent occlusion in COVID-19 patient: Case report. Int J Surg Case Rep 2021; 84:106133.</a></li><li><a class="nounderline abstract_t">Giacomelli E, Dorigo W, Fargion A, et al. Acute Thrombosis of an Aortic Prosthetic Graft in a Patient with Severe COVID-19-Related Pneumonia. Ann Vasc Surg 2020; 66:8.</a></li><li><a class="nounderline abstract_t">Schultz K, Wolf JM. Digital Ischemia in COVID-19 Patients: Case Report. J Hand Surg Am 2020; 45:518.</a></li><li><a class="nounderline abstract_t">Suarez-Valle A, Fernandez-Nieto D, Diaz-Guimaraens B, et al. Acro-ischaemia in hospitalized COVID-19 patients. J Eur Acad Dermatol Venereol 2020; 34:e455.</a></li><li><a class="nounderline abstract_t">Qian SZ, Pan JY. COVID-19 With Limb Ischemic Necrosis. J Cardiothorac Vasc Anesth 2020; 34:2846.</a></li><li><a class="nounderline abstract_t">Pavord S, Scully M, Hunt BJ, et al. Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis. N Engl J Med 2021; 385:1680.</a></li><li class="breakAll">Updated GTH statement on vaccination with the AstraZeneca COVID-19 vaccine, as of March 22, 2021. https://gth-online.org/wp-content/uploads/2021/03/GTH_Stellungnahme_AstraZeneca_engl._3_22_2021.pdf (Accessed on March 28, 2021).</li><li class="breakAll">Pai M, Grill A, Ivers A, et al. Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) Following AstraZeneca COVID-19 Vaccination. https://covid19-sciencetable.ca/sciencebrief/vaccine-induced-prothrombotic-immune-thrombocytopenia-vipit-following-astrazeneca-covid-19-vaccination/ (Accessed on March 31, 2021).</li><li><a class="nounderline abstract_t">Schultz NH, Sørvoll IH, Michelsen AE, et al. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. N Engl J Med 2021; 384:2124.</a></li><li><a class="nounderline abstract_t">Greinacher A, Thiele T, Warkentin TE, et al. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. N Engl J Med 2021; 384:2092.</a></li><li><a class="nounderline abstract_t">Jongkind V, Earnshaw JJ, Bastos Gonçalves F, et al. Editor's Choice - Update of the European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia in Light of the COVID-19 Pandemic, Based on a Scoping Review of the Literature. Eur J Vasc Endovasc Surg 2022; 63:80.</a></li><li class="breakAll">Vidali S, Morosetti D, Cossu E, et al. D-dimer as an indicator of prognosis in SARS-CoV-2 infection: a systematic review. ERJ Open Res. 2020; 6:00260.</li><li><a class="nounderline abstract_t">Fan BE, Chia YW, Sum CLL, et al. Global haemostatic tests in rapid diagnosis and management of COVID-19 associated coagulopathy in acute limb ischaemia. J Thromb Thrombolysis 2020; 50:292.</a></li><li><a class="nounderline abstract_t">Piazza G, Morrow DA. Diagnosis, Management, and Pathophysiology of Arterial and Venous Thrombosis in COVID-19. JAMA 2020; 324:2548.</a></li><li><a class="nounderline abstract_t">Colling ME, Kanthi Y. COVID-19-associated coagulopathy: An exploration of mechanisms. Vasc Med 2020; 25:471.</a></li><li><a class="nounderline abstract_t">Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 382:1708.</a></li><li><a class="nounderline abstract_t">Han H, Yang L, Liu R, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med 2020; 58:1116.</a></li><li><a class="nounderline abstract_t">Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020; 18:844.</a></li><li class="breakAll">Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020 28; 396:1054.</li><li><a class="nounderline abstract_t">Baccellieri D, Bilman V, Apruzzi L, et al. A Case of Covid-19 Patient with Acute Limb Ischemia and Heparin Resistance. Ann Vasc Surg 2020; 68:88.</a></li><li><a class="nounderline abstract_t">Andina D, Noguera-Morel L, Bascuas-Arribas M, et al. Chilblains in children in the setting of COVID-19 pandemic. Pediatr Dermatol 2020; 37:406.</a></li><li><a class="nounderline abstract_t">Gottlieb M, Long B. Dermatologic manifestations and complications of COVID-19. Am J Emerg Med 2020; 38:1715.</a></li><li><a class="nounderline abstract_t">Lodigiani C, Iapichino G, Carenzo L, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 2020; 191:9.</a></li><li><a class="nounderline abstract_t">Parisi R, Costanzo S, Di Castelnuovo A, et al. Different Anticoagulant Regimens, Mortality, and Bleeding in Hospitalized Patients with COVID-19: A Systematic Review and an Updated Meta-Analysis. Semin Thromb Hemost 2021; 47:372.</a></li><li><a class="nounderline abstract_t">White D, MacDonald S, Bull T, et al. Heparin resistance in COVID-19 patients in the intensive care unit. J Thromb Thrombolysis 2020; 50:287.</a></li><li><a class="nounderline abstract_t">Lisman T, Thachil J. Differentiating biochemical from clinical heparin resistance in COVID-19. J Thromb Thrombolysis 2020; 50:1015.</a></li><li><a class="nounderline abstract_t">McGlynn F, McGrath J, Varghese C, et al. Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection. J Thromb Thrombolysis 2021; 51:243.</a></li><li><a class="nounderline abstract_t">Lozano R, Franco ME. Incidence of heparin-induced thrombocytopenia in patients with 2019 coronavirus disease. Med Clin (Engl Ed) 2020; 155:409.</a></li><li><a class="nounderline abstract_t">Daviet F, Guervilly C, Baldesi O, et al. Heparin-Induced Thrombocytopenia in Severe COVID-19. Circulation 2020; 142:1875.</a></li><li><a class="nounderline abstract_t">Rutherford RB. Acute limb ischemia: Clinical assessment and standards for reporting. Semin Vasc Surg 1992; 5:4.</a></li><li><a class="nounderline abstract_t">Campbell WB, Ridler BM, Szymanska TH. Two-year follow-up after acute thromboembolic limb ischaemia: the importance of anticoagulation. Eur J Vasc Endovasc Surg 2000; 19:169.</a></li><li><a class="nounderline abstract_t">D'Oria M, Mills JL Sr, Cohnert T, et al. The "Vascular Surgery COVID-19 Collaborative" (VASCC). Eur J Vasc Endovasc Surg 2020; 60:489.</a></li><li><a class="nounderline abstract_t">Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 2020; 323:2052.</a></li><li><a class="nounderline abstract_t">Kaur S, Bansal R, Kollimuttathuillam S, et al. The looming storm: Blood and cytokines in COVID-19. Blood Rev 2021; 46:100743.</a></li><li><a class="nounderline abstract_t">Jain A, Reddy A, Murugesan R, et al. Outcomes of Patients With Acute Limb Ischemia in Patients With COVID-19: A Systemic Review and Meta-Analysis. Cureus 2022; 14:e27370.</a></li><li><a class="nounderline abstract_t">Bonaca MP, Gutierrez JA, Creager MA, et al. Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50). Circulation 2016; 133:997.</a></li><li><a class="nounderline abstract_t">Inagaki E, Farber A, Kalish JA, et al. Outcomes of Peripheral Vascular Interventions in Select Patients With Lower Extremity Acute Limb Ischemia. J Am Heart Assoc 2018; 7.</a></li><li><a class="nounderline abstract_t">Baril DT, Patel VI, Judelson DR, et al. Outcomes of lower extremity bypass performed for acute limb ischemia. J Vasc Surg 2013; 58:949.</a></li><li><a class="nounderline abstract_t">Mouhayar E, Tayar J, Fasulo M, et al. Outcome of acute limb ischemia in cancer patients. Vasc Med 2014; 19:112.</a></li><li><a class="nounderline abstract_t">Björck M, Boyle JR, Dick F. The Need of Research Initiatives Amidst and After the Covid-19 Pandemic: A Message from the Editors of the EJVES. Eur J Vasc Endovasc Surg 2020; 59:695.</a></li><li><a class="nounderline abstract_t">Mouawad NJ, Cuff RF, Hultgren R, et al. The Vascular Surgery COVID-19 Collaborative (VASCC). J Vasc Surg 2020; 72:379.</a></li><li class="breakAll">Vascular Surgery COVID-19 Collaborative (VASCC) https://medschool.cuanschutz.edu/surgery/specialties/vascular/research/vascular-surgery-covid-19-collaborative (Accessed on November 24, 2020).</li></ol></div><div id="topicVersionRevision">Topic 128913 Version 14.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32349133" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32305883" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32282949" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Hematological findings and complications of COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32311448" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33282586" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Coronavirus-Associated Coagulopathy: Lessons From SARS-CoV1 and MERS-CoV for the Current SARS-CoV2 Pandemic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16807662" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Analysis of thrombotic factors in severe acute respiratory syndrome (SARS) patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32360371" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Thromboembolic events in patients with SARS-CoV-2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34144749" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : A review of acute limb ischemia in COVID-positive patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34144749" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : A review of acute limb ischemia in COVID-positive patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32348233" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33549252" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Arterial Thrombotic Events in Adult Inpatients With COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32866580" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Acute Arterial Thromboembolism in Patients with COVID-19 in the New York City Area.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32360679" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Acute limb ischemia in patients with COVID-19 pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35793687" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Arterial Thrombotic Events in Hospitalized COVID-19 Patients: A Short Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32866574" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Arterial Thrombosis in Coronavirus Disease 2019 Patients: A Rapid Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26350058" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Population-Based Study of Incidence, Risk Factors, Outcome, and Prognosis of Ischemic Peripheral Arterial Events: Implications for Prevention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31238713" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Acute Limb Ischemia in Peripheral Artery Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32222135" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Rivaroxaban in Peripheral Artery Disease after Revascularization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32222135" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Rivaroxaban in Peripheral Artery Disease after Revascularization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32222135" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Rivaroxaban in Peripheral Artery Disease after Revascularization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32702090" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34390791" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Acute limb ischemia among patients with COVID-19 infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33102991" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Acute aortoiliac and infrainguinal arterial thrombotic events in four patients diagnosed with the novel coronavirus 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33500313" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Axillary artery thrombosis resulting in upper limb amputation as a COVID-19 sequela.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32417015" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Risk of peripheral arterial thrombosis in COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33628656" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : COVID-19 Induced Bilateral Lower Limb Ischemia and Visceral Infarcts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32423583" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Acute limb ischaemia in two young, non-atherosclerotic patients with COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33737827" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Acute Lower Limb Ischemia in Patients Infected with COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32487122" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Thrombotic and hemorrhagic events in critically ill COVID-19 patients: a French monocenter retrospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32673190" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Lower-extremity Arterial Thrombosis Associated with COVID-19 Is Characterized by Greater Thrombus Burden and Increased Rate of Amputation and Death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36036760" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32934901" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Severe ischemic complications in Covid-19-A case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27851992" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9308598" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Recommended standards for reports dealing with lower extremity ischemia: revised version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12556737" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Clinical diagnosis and prognosis of acute limb ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16549646" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32912089" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Bilateral Acute Lower Limb Ischemia Secondary to COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32918938" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Unusual arterial thrombotic events in Covid-19 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33820491" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Symptomatic arterial thrombosis associated with novel coronavirus disease 2019 (COVID-19): report of two cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32889160" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : COVID-19 Infection and Arterial Thrombosis: Report of Three Cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32939794" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Emergency management of the COVID-19 pandemic in a vascular surgery department of a large metropolitan hospital in Italy. Preparation, escalation, de-escalation, and normal activity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33948415" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Acute Limb Ischemia as the Initial Severe Presentation in COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34044096" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Misdiagnosed Acute Limb Ischemia in Three Nonhospitalized Patients Recovering From a Nonsevere COVID-19 Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34049454" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Arterial Thrombosis and Acute Limb Ischemia as a Complication of COVID-19 Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/100" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Bovine mannosidosis--a model lysosomal storage disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/98" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Microbial sources of cellulase.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34316528" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Acute limb ischemia and aortic mural thrombosis as primary manifestations of severe acute respiratory syndrome coronavirus 2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33082089" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Acute Limb Ischemia in Minimally Symptomatic SARS-CoV-2 Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32864520" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Acute limb ischemia as sole initial manifestation of SARS-CoV-2 infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32523927" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : COVID-19 Presenting as Acute Limb Ischaemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32850218" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Covid-19 Presenting as Acute Limb Ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32844136" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Acute upper limb ischemia as the first manifestation in a patient with COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32791191" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Acute Lower Limb Ischemia as Clinical Presentation of COVID-19 Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33940162" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Arterial Thrombotic Sequalae After Covid-19: Mind the Gap.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34191222" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : A clinical case series of COVID-19-associated acute limb ischemia: real-world situation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32763457" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Single-Center Vascular Hub Experience after 7 weeks of COVID-19 Pandemic in Lombardy (Italy).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34341687" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Acute limb ischemia with concomitant splenic and renal infarcts: Thromboembolic events revealing COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34122702" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Concomitant acute limb ischemia and multiple acute ischemic strokes complicating COVID-19: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33477081" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Aorto-iliac/right leg arterial thrombosis necessitating limb amputation, pulmonary arterial, intracardiac, and ilio-caval venous thrombosis in a 40-year-old with COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34119938" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Staged acute mesenteric and peripheral ischemia treatment in COVID-19 patient: Case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33819591" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Acute Limb Ischemia in Hospitalized COVID-19 Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33335817" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Acute Limb Ischemia: A Rare Complication of COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/110" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Polypsychopharmacy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32405288" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Acute upper limb ischemia in a patient with COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32561269" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Acute limb ischemia in COVID-19 patients: Could aortic floating thrombus be the source of embolic complications?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33039110" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Acute arterial and deep venous thromboembolism in COVID-19 patients: Risk factors and personalized therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33388408" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Acute Limb Ischemia in a Peruvian Cohort Infected by COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33281415" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : SARS-CoV-2 and limb ischemia: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33200030" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Large vessel thrombosis in patient with COVID-19, a case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33968287" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : COVID-19 and arterial thrombosis: Report of 2 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34182111" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Treatment-Resistant Acute Upper Limb Ischemia in a Patient With Systemic Lupus Erythematous and Concomitant SARS-CoV-2 Infection: A Case Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34258131" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Aortic Thrombosis and Acute Limb Ischemia Secondary to COVID Hypercoagulability.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32661487" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Coagulopathy in COVID-19 infection: a case of acute upper limb ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33062472" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Acute Upper Limb Ischemia Due To Arterial Thrombosis in a Mild COVID-19 Patient: A Case Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32802604" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Acute Limb Ischemia in COVID-19 Disease: A Mysterious Coagulopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32747597" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : COVID-19 associated with extensive pulmonary arterial, intracardiac and peripheral arterial thrombosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32713821" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Bilateral Acute Cardioembolic Limb Ischemia After Coronavirus Disease 2019 Pneumonia in a Lung Transplant Recipient: A Case Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32733710" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Early Left Ventricular Thrombus Formation in a COVID-19 Patient with ST-Elevation Myocardial Infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32447121" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Unheralded Lower limb threatening ischemia in a COVID-19 patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32861850" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Systemic Thrombolysis as Initial Treatment of COVID-19 Associated Acute Aortoiliac and Lower Extremity Arterial Thrombosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32696003" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Acute Limb Ischemia Due to Arterial Thrombosis Associated With Coronavirus Disease 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34175678" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Mechanical rotational thrombectomy in long femoropopliteal artery and stent occlusion in COVID-19 patient: Case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32360432" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Acute Thrombosis of an Aortic Prosthetic Graft in a Patient with Severe COVID-19-Related Pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32387155" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Digital Ischemia in COVID-19 Patients: Case Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32378743" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Acro-ischaemia in hospitalized COVID-19 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32359711" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : COVID-19 With Limb Ischemic Necrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34379914" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34379914" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34379914" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33835768" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33835769" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34686452" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Editor's Choice - Update of the European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia in Light of the COVID-19 Pandemic, Based on a Scoping Review of the Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34686452" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Editor's Choice - Update of the European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia in Light of the COVID-19 Pandemic, Based on a Scoping Review of the Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32474758" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Global haemostatic tests in rapid diagnosis and management of COVID-19 associated coagulopathy in acute limb ischaemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33226423" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Diagnosis, Management, and Pathophysiology of Arterial and Venous Thrombosis in COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32558620" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : COVID-19-associated coagulopathy: An exploration of mechanisms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32109013" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Clinical Characteristics of Coronavirus Disease 2019 in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32172226" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32073213" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32073213" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32589931" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : A Case of Covid-19 Patient with Acute Limb Ischemia and Heparin Resistance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32386460" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Chilblains in children in the setting of COVID-19 pandemic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32731141" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Dermatologic manifestations and complications of COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32353746" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33851386" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Different Anticoagulant Regimens, Mortality, and Bleeding in Hospitalized Patients with COVID-19: A Systematic Review and an Updated Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32445064" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Heparin resistance in COVID-19 patients in the intensive care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32880796" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Differentiating biochemical from clinical heparin resistance in COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32830309" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33072866" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Incidence of heparin-induced thrombocytopenia in patients with 2019 coronavirus disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32990022" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Heparin-Induced Thrombocytopenia in Severe COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Acute limb ischemia: Clinical assessment and standards for reporting</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10727366" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Two-year follow-up after acute thromboembolic limb ischaemia: the importance of anticoagulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32798205" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : The "Vascular Surgery COVID-19 Collaborative" (VASCC).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32320003" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32829962" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : The looming storm: Blood and cytokines in COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36046311" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Outcomes of Patients With Acute Limb Ischemia in Patients With COVID-19: A Systemic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26826179" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29650705" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Outcomes of Peripheral Vascular Interventions in Select Patients With Lower Extremity Acute Limb Ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23714364" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Outcomes of lower extremity bypass performed for acute limb ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24532704" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Outcome of acute limb ischemia in cancer patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32303451" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : The Need of Research Initiatives Amidst and After the Covid-19 Pandemic: A Message from the Editors of the EJVES.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32334050" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : The Vascular Surgery COVID-19 Collaborative (VASCC).</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
